Kimberly leads Communications at Cognito Therapeutics. She is founder and CEO of KKH Advisors, a life sciences and digital health strategic communications firm. She was previously Senior Director at FTI Consulting, Life Sciences and Healthcare, Capital Markets, where she advised a broad range of clients from Fortune 500 to early-stage companies on business transformation, corporate and executive positioning, crisis and issues management, and financial communications with a focus on IPO readiness. Prior to FTI Consulting (NYSE: FCN), a global business advisory firm, she was Global Editor at BioPharm Insight, a business intelligence product launched by the Financial Times Group. She started her career as an M&A reporter in Hong Kong covering Asia-Pacific healthcare and transferred to New York to cover US pharmaceuticals in 2007. She has been a guest lecturer at Columbia University and Georgetown University on change management communications and a guest speaker at Weill Cornell Medicine Bioventure eLab. She has a BA in Psychology from New York University.